BONIFAZI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 3.297
EU - Europa 1.430
AS - Asia 1.122
SA - Sud America 122
AF - Africa 47
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.060
Nazione #
US - Stati Uniti d'America 3.206
CN - Cina 419
SG - Singapore 330
RU - Federazione Russa 327
IT - Italia 315
DE - Germania 279
VN - Vietnam 131
BR - Brasile 100
GB - Regno Unito 86
HK - Hong Kong 84
SE - Svezia 81
UA - Ucraina 72
CA - Canada 67
FR - Francia 67
FI - Finlandia 64
IN - India 38
ZA - Sudafrica 33
TR - Turchia 32
AU - Australia 30
PL - Polonia 28
KR - Corea 25
IE - Irlanda 22
CZ - Repubblica Ceca 20
BE - Belgio 19
JP - Giappone 18
ES - Italia 14
MX - Messico 14
HR - Croazia 12
NL - Olanda 11
EU - Europa 10
IQ - Iraq 9
AR - Argentina 8
PK - Pakistan 8
BD - Bangladesh 7
EC - Ecuador 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
KE - Kenya 4
CL - Cile 3
EG - Egitto 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
IS - Islanda 2
LT - Lituania 2
MA - Marocco 2
PA - Panama 2
SN - Senegal 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 6.060
Città #
Dallas 499
Fairfield 282
Ashburn 271
Singapore 208
Woodbridge 180
Jacksonville 170
Houston 156
San Jose 131
Chandler 126
Ann Arbor 123
Seattle 100
Wilmington 97
Cambridge 95
Hong Kong 79
Boardman 77
Beijing 68
Camerino 64
Dearborn 56
Los Angeles 54
Nanjing 54
Ho Chi Minh City 50
Toronto 46
New York 45
Orem 42
Munich 39
Hanoi 35
Helsinki 30
Johannesburg 30
San Mateo 26
Moscow 25
Istanbul 24
Milan 24
Seoul 24
Tongling 24
Nanchang 23
Dublin 22
Lauterbourg 22
Lawrence 22
Princeton 22
The Dalles 20
Santa Clara 19
Shanghai 19
Brno 17
Brussels 17
Buffalo 17
London 17
Turku 17
Kraków 16
Kunming 16
Columbus 15
Jinan 15
Ogden 15
Sydney 15
Düsseldorf 13
Redwood City 13
Tokyo 13
Manchester 12
Rome 12
Shenyang 12
Chennai 11
Frankfurt am Main 11
Jiaxing 11
Morgantown 11
Poplar 11
Stockholm 11
Warsaw 11
Melbourne 10
Monmouth Junction 10
Philadelphia 10
Brooklyn 9
Council Bluffs 9
Hebei 9
Hefei 9
Lachine 9
Mumbai 9
Ningbo 9
Ascoli Piceno 8
Changsha 8
Nürnberg 8
San Diego 8
São Paulo 8
Chicago 7
Montreal 7
Nantong 7
Nuremberg 7
Amsterdam 6
Augusta 6
Centro 6
Guangzhou 6
Islamabad 6
Perugia 6
Phoenix 6
Tianjin 6
Tulsa 6
Ankara 5
Barcelona 5
Da Nang 5
Haiphong 5
Hangzhou 5
Hanover 5
Totale 4.097
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 627
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 615
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 326
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 303
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 294
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 253
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 246
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 240
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 238
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 225
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 216
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 213
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 209
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 202
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 190
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 183
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 179
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 178
Molecular and Stereochemical Requirements of 1,4-Dioxane Ligands for the Interaction with Different Receptor Systems 178
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 176
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 173
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 159
null 129
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 110
Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation. 109
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 105
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2 77
Totale 6.153
Categoria #
all - tutte 20.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 50 99 38
2021/2022302 38 78 3 15 23 10 10 17 25 41 10 32
2022/2023365 46 18 32 39 42 36 4 19 59 17 36 17
2023/2024282 27 16 27 10 13 28 19 10 25 8 5 94
2024/20251.027 51 7 84 42 25 64 136 215 89 61 88 165
2025/20261.958 103 153 536 280 191 112 218 126 99 140 0 0
Totale 6.153